General Range
FORCOF-L
Price on request/100 · MOQ 100 boxes
FORCOF-L Syrup by Fortune Labs contains Levosalbutamol, Guaiphenesin, and Ambroxol Hydrochloride, a combination formulated for managing productive cough and chest congestion. Levosalbutamol is a bronchodilator that helps relax airway muscles and improve airflow. Guaiphenesin acts as an expectorant to facilitate mucus clearance, while Ambroxol Hydrochloride helps thin thick mucus, making it easier to expel. FORCOF-L may be prescribed for selected respiratory conditions involving mucus production and bronchospasm when clinically appropriate. Available in convenient 60 ml sugar-free syrup packaging, this product is part of Fortune Labs' respiratory pharmaceutical portfolio. Fortune Labs offers Respiratory PCD Pharma Franchise and distribution opportunities across India. Contact the company for wholesale pricing, product availability, and franchise enquiries. Use only as prescribed by a healthcare professional.
CategoryGeneral Range
Min. Order100 boxes
Supplied byFortune Labs
CertificationWHO-GMP, ISO
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Specifications
- Composition
- Levosalbutamol + Guaiphenesin + Ambroxol Hydrochloride Syrup
- Packaging Type
- Syrup Bottle with Outer Carton
- Packaging Size
- 60 ml
- Dosage Form
- Oral Syrup
- Treatment
- Productive cough (cough with mucus), chest congestion, thick mucus, bronchitis, and breathing difficulties associated with mucus-producing respiratory
- Shelf Life
- 24 Months
- Storage
- Store below 30°C, protect from light & moisture
- Certification
- WHO-GMP, ISO
Company Info
Fortune LabsPanchkula, Haryana
Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.
Key Details
• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.
Product Portfolio & Therapeutic Ranges
• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?
More General Range
